From USFDA
Zydus Cadila's Formulations Manufacturing Facility at Pharma SEZ, Ahmedabad has received an Establishment Inspection Report from the USFDA signifying the successful closure of the audit. The manufacturing plant had completed the USFDA audit from 16 to 24 January 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
